首页> 外文OA文献 >Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma

【2h】

Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma

机译：羧基酯酶-2的过度表达导致甲基异构酶I抑制剂，伊替康（CPT-11）的疗效增强了多种骨髓瘤的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroki Yano; Satoshi Kayukawa; Shinsuke Iida; Chiharu Nakagawa; Tetsuya Oguri; Takaomi Sanda; Jianming Ding; Fumiko Mori; Asahi Ito; Masaki Ri; Atsushi Inagaki; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Hiroshi Inagaki; Atsushi Suzuki; Ryuzo Ueda;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma. [J] . Yano H, Kayukawa S, Iida S, Cancer science. . 2008,第11期

机译：羧酸酯酶2的过表达导致拓扑异构酶I抑制剂伊立替康（CPT-11）对多发性骨髓瘤的疗效增强。
2. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma [J] . Priya Choudhry, Margarette C. Mariano, Huimin Geng, Leukemia . 2020,第3期

机译：DNA甲基转移酶抑制剂上调CD38蛋白表达，并在多发性骨髓瘤中提高达拉穆巴布疗效
3. Histone Deacetylase Inhibitors with or without AKT Inhibition Potentially Increase the Efficacy of Daratumumab in Multiple Myeloma By Enhancing the Antibody-Dependent Cell-Mediated and Complement-Dependent Cytotoxicity As Well As Apoptosis [J] . Hirano Mitsuhito, Imai Yoichi, Ung Weng-Chit, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：具有或没有Akt抑制的组蛋白脱乙酰酶抑制剂可能通过增强依赖于依赖于依赖的细胞介导和补体依赖性细胞毒性以及细胞凋亡来提高多个骨髓瘤中的达拉内巴布的疗效
4. New cancer-treatment model of photodynamic therapy combined with a type I topoisomerase inhibitor CPT-11 against HeLa cell tumors in nude mice used by OPO parametric tunable laser [C] . Takato O. Yoshida, Hamamatsu Univ. School of Medicine, Hamamatsu, 5th International Photodynamic Association Biennial Meeting . 1995

机译：OPO参数可调激光使用光动力疗法联合I型拓扑异构酶抑制剂CPT-11对抗裸鼠HeLa细胞肿瘤的新癌症治疗模型
5. Heparanase drives the aggressive myeloma phenotype: Preclinical development of a heparanase inhibitor for the treatment of multiple myeloma. [D] . Ritchie, Joseph P. 2010

机译：乙酰肝素酶驱动侵袭性骨髓瘤表型：用于治疗多发性骨髓瘤的乙酰肝素酶抑制剂的临床前开发。
6. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma [O] . Priya Choudhry, Margarette C. Mariano, Huimin Geng, -1

机译：DNA甲基转移酶抑制剂上调CD38蛋白表达并增强daratumumab在多发性骨髓瘤中的疗效
7. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma [O] . Priya Choudhry, Margarette C. Mariano, Huimin Geng, 2019

机译：DNA甲基转移酶抑制剂上调CD38蛋白表达，并在多发性骨髓瘤中提高达拉穆巴布疗效

Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma

著录项

引文网络

相似文献

相关主题

期刊订阅